Glyceollins, One of the Phytoalexins Derived from Soybeans under Fungal Stress, Enhance Insulin Sensitivity and Exert Insulinotropic Actions

被引:51
作者
Park, Sunmin [1 ]
Ahn, Il Sung [1 ]
Kim, Jeong Hwan [2 ]
Lee, Mee Ryung [2 ]
Kim, Jong Sang [3 ]
Kim, Hyo Jung [3 ]
机构
[1] Nat Hoseo Univ, Coll Sci, Obes Diabet Ctr, Dept Food & Nutr, Asan 336795, South Korea
[2] Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci BK21, Jinju 660701, South Korea
[3] Kyungpook Natl Univ, Sch Life & Food Sci, Dept Anim Sci & Biotechnol, Taegu 702701, South Korea
关键词
Glucose uptake; peroxisome proliferator-activated receptor-gamma; insulin secretion; beta-cell apoptosis; glucagon-like peptide-1; ER stress; ENDOPLASMIC-RETICULUM STRESS; POSTMENOPAUSAL FEMALE MONKEYS; GLUCAGON-LIKE PEPTIDE-1; PANCREATIC BETA-CELLS; FREE FATTY-ACIDS; ADIPOCYTE DIFFERENTIATION; IN-VITRO; ESTROGEN; SECRETION; APOPTOSIS;
D O I
10.1021/jf903432b
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Glyceollins are a category of phytoalexins that are produced by soybeans under fungal stress, but their effects on glucose homeostasis remain unknown. We hypothesized that glyceollins play an important role in glucose homeostasis by regulating glucose utilization in adipocytes and improving beta-cell function and survival. Glyceollins improved insulin-stimulated glucose uptake in 3T3-L1 adipocytes without activating the peroxisome proliferator-activated receptor-gamma agonist. They decreased triacylglycerol accumulation in adipocytes. In addition, glyceollins slightly improved glucose-stimulated insulin secretion without palmitate treatment in Min6 cells, and they potentiated insulinotropic actions when 500 mu M palmitate was used to induce beta-cell dysfunction. This was associated with decreased beta-cell apoptosis because of the attenuation of endoplasmic reticulum stress, as determined by mRNA levels of XBP-1, ATF-4, ATF-6, and CHOP. Glyceollins also potentiated GLP-1 secretion to enhance insulinotropic actions in enteroendocrine cells. In conclusion, glyceollins help normalize glucose homeostasis by potentiating beta-cell function and survival and improving glucose utilization in adipocytes.
引用
收藏
页码:1551 / 1557
页数:7
相关论文
共 35 条
[1]   Beneficial role of dietary phytoestrogens in obesity and diabetes [J].
Bhathena, SJ ;
Velasquez, MT .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 76 (06) :1191-1201
[2]  
BONE SM, 2009, J AGR FOOD CHEM, V57, P2614
[3]   Phytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor α and β [J].
Burow, ME ;
Boue, SM ;
Collins-Burow, BM ;
Melnik, LI ;
Duong, BN ;
Carter-Wientjes, CH ;
Li, SF ;
Wiese, TE ;
Cleveland, TE ;
McLachlan, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1750-1758
[4]   Estrogen and exercise may enhance β-cell function and mass via insulin receptor substrate 2 induction in ovariectomized diabetic rats [J].
Choi, SB ;
Jang, JS ;
Park, SM .
ENDOCRINOLOGY, 2005, 146 (11) :4786-4794
[5]  
Fajas L, 1999, MOL CELL BIOL, V19, P5495
[6]   Gender Differences in Insulin Resistance, Body Composition, and Energy Balance [J].
Geer, Eliza B. ;
Shen, Wei .
GENDER MEDICINE, 2009, 6 :60-75
[7]   Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat [J].
Hallakou, S ;
Doare, L ;
Foufelle, F ;
Kergoat, M ;
GuerreMillo, M ;
Berthault, MF ;
Dugail, I ;
Morin, J ;
Auwerx, J ;
Ferre, P .
DIABETES, 1997, 46 (09) :1393-1399
[8]   Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival [J].
Hayashi, Teruo ;
Su, Tsung-Ping .
CELL, 2007, 131 (03) :596-610
[9]   Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 [J].
Hirasawa, A ;
Tsumaya, K ;
Awaji, T ;
Katsuma, S ;
Adachi, T ;
Yamada, M ;
Sugimoto, Y ;
Miyazaki, S ;
Tsujimoto, G .
NATURE MEDICINE, 2005, 11 (01) :90-94
[10]   Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome [J].
Huang, THW ;
Kota, BP ;
Razmovski, V ;
Roufogalis, BD .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (01) :3-14